The RCVS has announced the steps it will be taking in response to the Standards Committee's review of 24/7 emergency care.
Whilst the College has stopped short of making home visits entirely discretionary, it has confirmed that with regards to 24/7 emergency care overall:
This follows RCVS Council's agreement in principle on recommendations that flowed from the Standards Committee's comprehensive review of 24/7 emergency care. The review was triggered by a number of issues, including the profession's response to the Chikosi Disciplinary Hearing of June 2013.
The College says the recommendations were developed out of a detailed process of evidence gathering, which included 656 pages of views submitted to the College, 2,801 signatures to a petition on home visits, a three-day select-committee-style hearing where representatives from 15 organisations and a further 10 individuals gave their views, a snapshot of responses from 1,062 vets taking part in the RCVS Survey of the Professions, and an online survey of 1,250 animal owners.
Council praised the work, which had been carried out under the guidance of Standards Committee Chair Clare Tapsfield-Wright, and agreed that draft changes to the supporting guidance to the Code of Professional Conduct should be refined and agreed by the Standards Committee and published over the next couple of months.
Clare said: "This process was not carried out as a typical consultation, with proposals being issued for consideration: we really wanted to be open to the views of the profession and the public from the start.
"We found that the profession did not wish to remove the 24/7 requirement, but there was a lot of frustration and concern, particularly around safety, home visits, who should be seen, outsourcing and contingency planning.
"The Standards Committee looked in detail at all of these issues and I am delighted to have Council's support for the general direction of our proposals. We will now review some changes to the wording of the new guidance, to improve clarity, and publish it as soon as possible."
President Neil Smith said: "I am delighted with the way this process has been carried out. No doubt the outcome will not please everyone, but these changes are based on robust evidence.
"The approach taken by the Standards Committee forms a useful model that could be adapted to address other such issues that we may face in the future."
The presentation given to Council on 5 June can be downloaded from the RCVS website at https://www.rcvs.org.uk/news-and-events/news/council-agrees-new-emphasis-for-24-7-guidance/ .
BCF, Instrumentation Concept and VetSonic have collected 'VetSurgeon.org Best Stand Awards'; the first two at BEVA Congress and the latter at BCVA Congress.
Judging for the BEVA Congress awards was undertaken by members of BEVA Council. BCF picked up the Best Large Stand Award which was presented by outgoing President, Andrew Harrison.
Pictured left to right: BEVA President, Andrew Harrison, Gavin Mitchell and Carole Irvine of BCF, and John Alborough representing VetSurgeon.org.
Instrumentation Concept picked up the Best Shell Scheme Award
Pictured left to right: Outgoing BEVA President, Andrew Harrison; Tahir Afzac of Instrumentation Concept; John Alborough representing VetSurgeon.org, and Sheraz Ishaque of Instrumentation Concepts
At BCVA Congress, Vetsonic won the Best Stand Award.
Pictured left to right: Clare Walsh, Vetsonic Director; John Alborough, All Round Good Egg representing VetSurgeon.org; Gareth Hateley, then President BCVA and Sarah Vermont, Marketing Manager Vetsonic.
Animalcare has launched Vetaclean, a new range of disinfectants which the company says has a notably high kill activity against canine parvovirus and common feline viruses such as FIV, FeLV and FCV.
The range comprises Vetaclean Parvo Advance, a surface disinfectant-cleaner, Vetaclean enzymatic instrument detergent-cleaner, and an instrument disinfectant.
Animalcare Product Manager, Tony Liepman, said: "Veterinary nurses tell us that canine parvovirus is the most challenging and resistant pathogen they work with, and so we set this as our benchmark for the Vetaclean disinfectant products. Tested under EN protocols and having 99.99% + kill activity against parvovirus, our new disinfectants demonstrate high efficacy against a broad range of bacteria, including MRSA/MRSP, fungi, viruses, mycobacteria and spores.
"Infection control is in the spotlight at the moment, highlighted by initiatives from within and outside our industry. Firstly, the new Practice Standards Scheme - launched at the same time as our range - places great emphasis on having a rigorous biosecurity policy. This includes requirements for personal hygiene as well as cleanliness of premises and equipment. High-level decontamination of instruments and equipment is ensured through the Vetaclean two-stage process, which works with even soiled instruments or equipment, and in under 20 minutes. The products have also been designed to be suitable for use on the most specialised equipment seen in today’s practices, including flexible or rigid endoscopes, ultrasonic baths, aspirators, arthroscopes and re-processing machines.
"Importantly, the active ingredients in the Vetaclean range meet the criteria of the new EU Biocides Regulations, policed by the Health and Safety Executive in the UK, which came into effect on 1st September 2015. All products with biocidal activity now need to undergo a complex registration process, ensuring the products are not harmful to people, the environment or animals. The rigorous process may see many disinfectant manufacturers pull out of the market, resulting in less choice. Further, the Vetaclean range does not contain Poly (hexamethylene biguanide) hydrochloride (PHMB). The European Chemicals Agency (ECHA) is currently proposing that PHMB is listed as a category 2 carcinogen."
The Vetaclean Parvo Advance range includes a 1 litre lavender product in a self-dosing bottle, 5 litre apple and lemon-fragranced liquid concentrates and unfragranced large surface wipes. There are two different dilution rates: a general purpose dilution rate for most pathogens at 1:100 (10ml per litre), and a parvocidal dilution rate at 1:50 (20ml per litre). Animalcare says the alkaline-based formula ensures that the products are compatible with a wide range of materials and are non-staining. Both the enzymatic instrument cleaner and instrument disinfectant are available in 2 litre concentrates (incorporating a calibrated dosing reservoir).
The Vetaclean range is available now in wholesalers. The company has also produced a brochure Hygiene in practice, a guide to veterinary infection control from Animalcare, designed to help familiarise veterinary professionals with the principles and uses of the product range. There is also a special launch offer of Buy-4-Get-One-Free available from Animalcare representatives.
For further information, contact Animalcare on 01904 487687, or speak to your regional Animalcare representative: www.animalcare.co.uk/contact-us.
From October 2020 it will be mandatory for all owners to microchip their horses, ponies and donkeys, or face a fine of up to £200. The new Central Equine Database will then allow local authorities and police to track down the owners of dumped horses and make sure they are punished. It will also mean lost or stolen horses will be reunited with their owners more easily.
Lord Gardiner, Animal Welfare Minister, said: "The government shares the British public’s high regard for animal welfare and it is completely unacceptable that hundreds of horses and ponies are left abandoned every year by irresponsible owners.
"That is why we have today laid new regulations in Parliament requiring horses to be microchipped. This will bolster the ability of local authorities and police to identify abandoned animals, ensuring these beautiful creatures receive the care they deserve and that those who mistreat them will face the consequences."
The BVA has welcomed the move as an important step forward for horse welfare and the integrity of the UK food chain.
British Veterinary Association Senior Vice President Gudrun Ravetz said: "We welcome this announcement to extend compulsory microchipping and believe that the measures represent an important step forward for horse welfare and the integrity of the UK food chain. The one-off cost of microchipping a horse is minimal while the animal welfare benefits in terms of being able to identify lost, stolen, abandoned or fly grazing horses, and identify horses in the face of disease outbreak, as well as the benefits to the integrity of food chain safety, are enormous.
"Universal microchipping of domesticated horses ensures that the legislation has value, the cost of implementing the new Central Equine Database (CED) is not wasted, and that food safety is protected. Together these measures will protect horses, ponies and donkeys from irresponsible owners, help loving owners to be reunited with their animals and keep the food chain free from potentially contaminated horse meat."
The regulations for the database were laid in Parliament today and, subject to parliamentary approval, will come into force on 1 October 2018.
Krka says the new pack, available for cats and for toy, small, medium and large dogs, is designed to offer practices greater dispensing flexibility and to encourage quarterly visits and compliance with healthcare plans.
Selehold is presented in a pipette with a colour-coded cap and transparent tube to enable the owner to check when the full dose has been given. Each pipette is individually wrapped for ease of use and dispensing.
Ms Sabrina Jordan, Country Brand Manager for Krka, said: "We aim to optimise the value we give to our customers by offering them highly effective, tried and trusted, affordable generic medicines with added value.
"Selehold has proved a popular addition to our parasite control range because of its ease of use and cost-effectiveness.
"With many of our customers focusing on encouraging owners to visit the practice quarterly and to sign up to a healthcare plan for their pet, the 3-pack version of Selehold works well as it enables the practice to offer clients a high quality, good value solution that supports this compliance framework."
There were 22,000 nominations for this year's awards, which will be held at the Kimpton Clocktower Hotel in Manchester on 24th March.
Other finalists are:
Vet Nurse of the Year
Practice of the Year
Practice Support Staff of the Year
Practice Manager of the Year
James Barnes, head of sales and partnerships at Petplan, said: “We’re delighted to announce the finalists for this year’s Veterinary Awards.
"The awards celebrate the dedication and brilliant work carried out by some of the UK’s very best veterinary professionals.
"Congratulations to all the 2022 finalists on this fantastic achievement."
For further information on the awards visit www.petplanvet.co.uk.
Dechra Brand Manager Craig Sankey said: "It can be a very worrying time for owners if their pet is being investigated for, or diagnosed with, hypothyroidism and the new website aims to help them understand more about the condition, how it manifests itself and what they can expect on the management journey.
"Effective management of the condition can significantly improve a dog’s quality of life and prevents the development of other, potentially life-threatening conditions, for which treatment can be intensive and costly."
The website also has a Frequently Asked Questions section and an interactive log book for owners to fill in which can also be emailed to their veterinary surgeon to assist in tracking the dogs’ progress and ensure that treatment is at its optimal level.
For more information, visit www.hypothyroiddog.com
The study, published in Nature Scientific Reports, investigated the effect of culling in the first three licensed badger cull areas – Gloucestershire, Somerset and Dorset – using data from 2013 to 2017.
Gloucestershire and Somerset saw reductions in bTB incidence rates in cull areas relative to comparison areas of 66 per cent and 37 per cent respectively after four years. In Dorset, there was no change in incidence rates in cull areas relative to comparison areas after two years, but incidence dropped by 55 per cent in the same period in the 2km buffer zone around the edge of the cull area. Matched comparison areas were similar but not identical.
James Russell, BVA Junior Vice President said: "These findings are encouraging and offer further evidence that badger culling can result in significant reductions in the number of new cases of TB in cattle. However, they come with the caveat that the data only relates to the first three cull areas, and the variability within these alone makes it too early to draw firm conclusions that culling will reduce incidence significantly in all 40 areas where it is now taking place.
"BVA’s expert working group is currently considering all aspects of disease control looking at cattle testing, removal of reactors, compensation and control in other farmed animals as well as the culling and vaccination of badgers. The group will consider this additional evidence as we develop our new policy on bTB.
"We continue to support a comprehensive and evidence-based approach to tackling bTB, including the use of badger culling where there is a demonstrated need and where it is done safely, humanely and effectively as part of a comprehensive strategy.
"The best way of halting the spread of this devastating disease is enhancing our understanding of bTB and applying that evidence to the eradication process.”
MDC Exports is launching a cat cage at BSAVA Congress which it claims will revolutionise the way cats are cared for in veterinary surgeries
According to the company, plastic cages currently in use tend to harbour germs where cats have made scratches in their surfaces. This cage, however, is the first of its kind to be made from stainless steel, which cats' claws cannot damage.
MDC claims the hygienic Cat Cage will protect animals from disease and infection during their stay in surgery making for happier, healthier patients. The company says the stainless steel Cat Cage is strong, durable and can be flame sterilized. The handles can also be colour-coded, for example, yellow means neuter, red means post-anaesthetic and green means ready to go home. Each stainless steel Cat Cage also comes with a two-year free replacement guarantee.
For more information, visit MDC Exports at BSAVA Congress 2011 on stand 123. All visitors to the stand will receive a complimentary NipLok - the quick-release tourniquet that can be operated one-handed
Merial Animal Health has been found in breach of the NOAH Code of Practice for literature promoting the wormer Ivomec Super.
In the literature, Merial stated that Closantel injection (Janssen Animal Health) was effective against flukes aged 9 weeks or older, when in fact, at the time the undated brochure was distributed, Closantel was effective against flukes aged 7 weeks or older.
Merial did not dispute the facts alleged: the company had relied on an out-of-date detailer. The NOAH Code of Practice Committee emphasised the need for members to ensure, when giving comparative data in promotions, that up-to-date data is used. The SPC of any authorised product can be viewed on the VMD's website.
The Committee did commend Merial Animal Health for taking corrective action within two days of notification by the Complainant.
NOAH encourages those interested in finding out more to read the full details of the Committee's rulings on the NOAH website at www.noah.co.uk/code.
MSD has announced that the broad-spectrum clostridial disease vaccine for sheep and cattle, Bravoxin 10, is now available in a new 6 x 100ml farm vaccination pack. The pack contains enough vaccine for 600 sheep or 300 cattle boosters.
Buyers of the new farm pack will also get a free vaccine applicator worth £20. The new Bravoxin 10 applicator benefits from the sterimatic system, which protects and sterilises the vaccination needle with each injection. MSD says it can also be placed down between doses without risk of needle damage, self-injection or needing to remove the vaccine bottle.
Bravoxin 10 protects both cattle and sheep from clostridial diseases like blackleg and black disease, as well as other conditions caused by clostridial bacteria that usually kill the animal once infection has become established. The vaccine protects against disease caused by the 10 main clostridial bacteria; C. perfringens type A, C.perfringens type B, C.perfringens type C, C.perfringens type D, C.novyi type B, C.septicum, C.tetani, C.sordellii, C.haemolyticum and C.chauvoei.
SureFlap, a microchip pet product company, will be launching SureFeed, a new automatic cat feeder at the London Vet Show, Stand L32, on the 21st - 22nd November 2013.
The company, which already sells a range of microchip-operated pet doors, says the new products are designed to keep food fresh and the kitchen free of smells and flies.
SureFeed will be available in two models: the SureFeed Pet Feeder, which opens when any pet approaches, and the SureFeed Microchip Pet Feeder which in addition functions as a selective pet feeder that opens only when it identifies a cat with a registered microchip or RFID collar tag.
Both products feature a bowl which seals shut to keep wet food fresh.
Dr Nick Hill, inventor of SureFeed as well as founder and inventor of SureFlap says this is an exciting new development for the company: "Many cats are fussy eaters and prefer to eat food when it is fresh, others are on special diets and this can be a problem in multi-pet households. Even in households where each cat is on the same diet, a 'greedy' cat, or even dog, can eat most of the food. This can result in one pet becoming overweight while the other starts to lose condition. The SureFeed product range has been designed to address all these issues."
The SureFeed Microchip Pet Feeder recognises a cat's unique microchip number and when an authorised cat is present, the sealed lid over the bowl slides back to reveal the food. Once the cat has left the feeder, the lid slides back over the bowl. The SureFeed Pet Feeder features the same sealed lid which is triggered to open by any approaching pet, closing again when the pet has finished feeding.
Nick said: "The SureFeed product range is the culmination of two years' intensive development work. The feeders incorporate a number of features to maximise usability, such as the Microchip Pet Feeder's side guards and lid which folds up to the rear, which shield the food from other pets while the authorised cat is eating. The feeders are both easy to wipe clean and the food bowl, mat and lid can be removed and are dishwasher-safe.
"The SureFeed Pet Feeder and Microchip Pet Feeder are the first in a suite of pet feeding products from SureFlap incorporating sealed operation and flexible feeding options and we are looking forward to developing the range in the future."
SureFeed products will be available to order from early 2014 but in the meantime, you can see them in action at Stand L32 at the London Vet Show.
The expert panel consisted of Peter Sandøe (Denmark), Professor of Ethics and Welfare; Helle Friis Proschowsky (Denmark), a veterinary surgeon working with the Danish Kennel Club; Laurent Findji (France/UK), Specialist in Soft Tissue Surgery; Gudrun Ravetz (UK) – Senior Vice President, British Veterinary Association; Kristin Wear Prestrud (Norway) – Veterinary Scientific Director of the Norwegian Kennel Club and Åke Hedhammar (Sweden), Professor Emeritus in Internal Medicine (companion animals), a veterinary consultant for the Swedish Kennel Club and a member of the WSAVA Hereditary Disease Committee.
Kristin Wear Prestrud said: "Vets should dare to speak out. We must educate owners on all health and welfare matters, whether we are simply advising them that their dog is overweight or if we need to give advice on breeding or refuse planned Caesarean sections."
The panel's recommendations are:
At a practice level, veterinary professionals should:
At an organisational level, the veterinary profession should:
Photo: ponpimonsa_bibi/Shutterstock
Bayer Animal Health has launched a free mobile app for pet owners, offering a bespoke parasite treatment reminder service, to help them follow their parasite protection plan prescribed by their vet.
The app was launched following a survey that found that 65% of pet owners do not regularly use parasite treatment products and are not certain that their pet is adequately protected against fleas, ticks, lice, mites and intestinal worms1. In addition, 83% of owners do not realise full protection against parasites requires a combination of two or more treatment products, and 45% are not confident that they have the job under control2.
The app allows owners to develop an on-going parasite protection plan in line with their veterinary prescription and receive automated reminders on treatment dates. In addition, the app allows users to set reminders for vaccination boosters, other vet appointments, and entering special dates like their pet's birthday or grooming appointments.
Once downloaded, users can create a pet profile to keep track of all their information in one place, including breed details, microchip number, weight, and date of birth of their dogs, cats, rabbits and ferrets. A 'learn' section of the app is also available to provide owners with the general information about parasites and the risk they pose to pets and family members.
The Jungle for Pets app is initially available to download for iPhones and iPads, by searching 'Jungle for Pets' in the Apple App store or clicking here.
VetSurgeon downloaded the app to try it out. A very polished app which has the potential to be extremely useful for those of us that can't remember our own names, let alone when the dog is due to be wormed. Three problems we found, which will doubtless be ironed out in future updates: Firstly, whilst the app works on an iPad, it's sized for and looks better on an iPhone. Secondly, it demanded a photo of the dog for registration. Whilst that's easy enough to do with an iPhone, the app then froze when we tried. Perhaps it should be optional. Finally, whilst the app very usefully allows for reminders of non-Bayer products, it doesn't appear to allow the user to type in the name of the product, forcing it to be listed as 'other'. We suspect that anyone who can't remember treatment dates (probably most of us) also won't be able to remember what 'other' was, especially if there are more than one or two 'other' products.
References
Kellie Price, a Kent-based Registered Veterinary Nurse has been suspended from the Register for nine months by the RCVS RVN Disciplinary Committee after she admitted dishonestly creating four prescriptions, one of which was then fraudulently presented to a pharmacy.
The Committee heard that in January 2013, Miss Price, who did not attend the hearing and had no representation, had dishonestly created a prescription for two inhalers while working at a veterinary practice in Kent.
This prescription had been written and signed in the name of a locum veterinary surgeon, Cristiana Tudini MRCVS, without her knowledge or consent. The false prescription was subsequently presented to a pharmacy for dispensing.
In addition, in March 2013, Miss Price dishonestly created a further three prescriptions - one of which was written in the name of her colleague Cormac Higgins MRCVS, and two written in the name of Cristiana Tudini MRCVS without either's knowledge or consent. All four false prescriptions had been made out for Miss Price's Jack Russell terrier.
Upon discovering the false prescriptions, Mr Higgins asked Miss Price for an explanation and subsequently suspended her from her position pending further investigation. However, after being interviewed by Mr Higgins, she resigned before any in-house disciplinary hearing could take place. The allegations were then reported to both the RCVS and the police, the latter giving Miss Price a formal caution in respect of the false prescription made in January 2013.
In considering Miss Price's sanction, the RVN Disciplinary Committee took into account a number of aggravating and mitigating factors. In mitigation, it accepted Miss Price's explanation that, in the early hours of 6 January, she had suffered an asthma attack and that she had created the false prescription at work in a panic after realising her inhaler was empty and fearing a further asthma attack. The Committee also took into account a witness statement from Cormac Higgins MRCVS which described her as a "great nurse" and "good with patients and clients".
However, the Committee also considered aggravating factors including Miss Price's dishonesty and the fact that she then made further false prescriptions in March, although these were not then presented to a pharmacy.
Professor Noreen Burrows, who chaired the RVN Disciplinary Committee and spoke on its behalf, said: "The Committee is... satisfied that the admitted dishonesty amounts to disgraceful conduct in a professional respect [and] is satisfied that the respondent's conduct fell far short of the conduct to be expected of a registered veterinary nurse."
On deciding the sanction she added: "Taking into account all of the circumstances, the Committee has concluded that the suspension of the Respondent's name from the Register for a period of nine months is the proportionate sanction in this case."
The Committee's full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
The two 60-minute interactive sessions are taking place on Wednesday (21st April) at 12.30pm and 6pm, coinciding with the United Nation’s World Creativity and Innovation Day.
Each session will introduce a range of creative techniques that can be used to spur innovation. Different breakout groups will then have various problems to solve and will utilise these techniques to tackle challenges and issues encountered within everyday veterinary practice.
Sophie Rogers, RCVS ViVet Manager, said: "These creativity techniques are a framework for approaching problems, but the key to developing solutions to everyday tasks and problems is learning how to foster and harness the whole team's creative abilities. These workshops will provide the techniques to help you and your team overcome the common barriers to creativity and gain the tools and mindsets needed to break existing patterns and ways of doing things, generate new ideas, and improve creative self-leadership.”
The workshops will be hosted by Gill Stevens (pictured right), the Founding Director of Level Seven, a consultancy that specialises in merging coaching with design thinking methodology as a way to support innovation and team productivity, and Rick Harris, Founder of Customer Faithful, a research-led consultancy, specialising in customer research, proposition design and employee engagement.
Veterinary professionals can sign up to the sessions, which count towards their continuing professional development (CPD) requirement, via the ViVet website at: www.vivet.org.uk/interactive-workshop-on-creative-thinking/
Propomitor can be used for the induction and maintenance of general anaesthesia for procedures lasting up to five minutes by the administration of incremental doses or as a constant rate infusion (CRI).
It can also be used for the induction of general anaesthesia where maintenance is provided by the inhalation of anaesthetic agents.
Animalcare Product Manager Kai Crawshaw said: "Propofol is the ‘go to’ solution for short-acting anaesthesia in many practices so we are delighted to add Propomitor, our new affordable propofol solution, to our range. It complements our already extensive anaesthetic toolkit, which offers options for analgesia, sedation, gaseous anaesthesia and recovery."
Propomitor is available in boxes of 5 x 20 ml bottles.
For more information, contact your Animalcare Territory Manager or Animalcare’s head office on 01904 487687.
Gabbrovet Multi is the first and only ready-to-use solution licensed to treat both cryptosporidium and E.coli diarrhoea in calves.
The company highlights a study of 334 calves with severe diarrhoea, where those receiving Gabbrovet Multi showed a faster and more effective response than those given halofuginone1.
Harry Walby, ruminant veterinary advisor at Ceva Animal Health, said: “Gabbrovet Multi is the first and only ready-to-use solution for the convenient treatment of both cryptosporidium and E.coli, two of the most common causes of neonatal scour in calves."
Gabbrovet Multi can be administered in milk or water.
It is available with a dosing cap and comes in 250ml, 500ml or 1l presentations.
Gabbrovet Multi also treats gastro-intestinal infections caused by E.coli in pigs.
For further information, contact your local Ceva Animal Health territory manager or email cevauk@ceva.com.
The AHT has published the first research paper of its kind which looks at idiopathic epilepsy (IE) in the Italian Spinoni, a breed where the prevalence of IE has been found to be 5.3%, compared to 0.6% estimated to be seen in dogs generally in UK first opinion practice.
Dr Luisa De Risio, Head of Neurology at the AHT and lead researcher on the paper, said: "Idiopathic epilepsy is the most common chronic neurologic disorder in dogs but it can be more common in some breeds than others, for example Irish Wolfhounds, Border Collies and Italian Spinoni. Sadly, we see a lot epileptic dogs in our clinic, including these breeds as well as Golden Retrievers and Labrador Retrievers, so research being undertaken at the AHT, and around the world, is very important in helping owners of dogs with epilepsy to be able to control the effects of the disease.
"The Italian Spinone is a wonderful breed but is highly affected by idiopathic epilepsy. To our knowledge, no one has conducted such a large-scale research study in this breed to be able to gain a better understanding of how the epilepsy manifests, how prevalent it really is and, importantly, which factors may contribute to survival in these dogs.
"With the backing of the Italian Spinone Club of Great Britain, the AHT was able to design a questionnaire for the research study and work with the Kennel Club to invite over 3,000 Kennel Club registered Italian Spinone owners to aid our research by completing the questionnaire.
"1,192 owners participated in the research and of this sample, 63 Italian Spinoni had IE. Owners of affected dogs were then invited to complete a further questionnaire and asked to make the dog's medical records available. This gave us a very large amount of data to analyse from which we were able to glean a lot of very useful information about the clinical characteristics of idiopathic epilepsy in Italian Spinoni."
The research also looked at survival times of those dogs in the study with IE. Survival was significantly longer in Italian Spinone with no cluster seizures and in Italian Spinone in which antiepileptic medication was initiated after the second seizure rather than after more than three seizures.
Luisa continued: "From this sample we were able to conclude that idiopathic epilepsy in this breed often has a severe presentation but starting treatment with antiepileptic medication after the second seizure, and aggressive treatment of cluster seizures, may improve the survival of these dogs.
"The input in treatment design and modulation by a specialist veterinary neurologist with expertise in canine epilepsy can help to optimise treatment success and the dog's quality of life.
"We hope these findings will help to increase veterinary knowledge and understanding of this horrible disease and give Italian Spinoni, and other affected breeds, the best chance of fighting IE.
"Epilepsy is one of the most complex and difficult diseases to treat, with several variables in any case, but it is important for owners not to give up hope and to seek a consultation with a veterinary neurologist who specialises in epilepsy, if possible."
The next phase of the AHT's research in the Italian Spinone is to identify the genetic basis of this condition, with the aim of identifying the genetic mutations responsible so that a genetic test could be created. This research is currently on-going in Italian Spinoni and Border Collies and requires more DNA samples from affected and unaffected dogs.
Luisa said: "A genetic test is the only way to successfully help breeders identify carriers and select matings which are most likely to produce unaffected dogs. However, the genetics, like the condition itself, are very complex so the development of such a test is still likely to be many years away. The most we can do for these lovely dogs now is to share these findings across the veterinary profession and to do our best to treat each dog as well as we can."
The full paper is titled 'Idiopathic Epilepsy in the Italian Spinone in the United Kingdom: Prevalence, Clinical Characteristics, and Predictors of Survival and Seizure Remission' and is published in the Journal of Veterinary Internal Medicine on an open-access basis.
Photo: © Caroline Granycome
As a result, clients of LV=GI and Waggel will be able to book an online appointment with a veterinary surgeon within 30 minutes, without having to pay FirstVet's normal £20-30 charge.
Waggel is FirstVet's 26th insurance partner globally, and its third in the UK. The company now has 150 veterinary surgeons working on the platform.
Lucy Broadbridge, LV= GI Pet Product Manager, said: “At LV= GI we’re always looking for ways to help our customers protect what they love, so we’re very excited to be able to work with FirstVet to provide this service to our pet customers. With access to a vet from your smartphone or device, our pet customers will have peace of mind knowing that qualified veterinary advice is on hand 24/7, avoiding unnecessary time, cost and distress of visiting their vet if they don’t really need to."
Under current legislation, there is very little practical assistance that can be offered via an online consultation, other than recommending whether or not the animal needs to be seen by a veterinary surgeon in person. It may also be the case that the online consultation offers little more than a pet owner would get by ringing their normal vet. Nevertheless, online consultations will doubtless grow significantly in 2020, as the players line up to take advantage of any relaxation in the regulations that they hope will allow veterinary surgeons to prescribe medicines for animals they have not seen in person.
Regardless of whether that happens, there is a value in face-to-face communication between a veterinary surgeon or nurse and a client, whether it be for triage or follow up consultations. Independent practices might therefore be well advised to start implementing this kind of technology in practice sooner rather than later, in particular looking at ways that online appointments could be scheduled (perhaps between normal consultations) so as to compete with the short waiting times offered by companies like FirstVet.
With Vetscan Imagyst, samples are prepared in-clinic using traditional methods, but submitted digitally, rather than sending physical slides to a laboratory. In this way, results are available in hours, allowing vets to offer same-day diagnosis and treatment.
The company says the new digital cytology application offers fast, accurate reviews of common cytology specimens, such as fine-needle aspirates,
Jamie Brannan, President International Operations, Zoetis said: "Veterinarians have told us that Vetscan Imagyst technology helps them make better informed decisions in a more transparent way for pet owners. With the cytology feature, Vetscan Imagyst will now offer one platform for multiple tests.”
He added: “We are excited to build on the incredible momentum that began with the AI fecal analysis launch. Vetscan Imagyst has been a significant part of the Zoetis portfolio and continues to evolve to meet diagnostic needs in practices around the world. The unique all-in-one technology has added immense value to veterinary clinics, facilitating fast, more accurate results, leading to quicker diagnoses and decisions that ultimately strengthen the bond of trust between veterinarians and their clients.”
For more information, contact your Zoetis representative or visit www.vetscanimagyst.com
Bayer Animal Health has launched Baytril® Max 100mg/ml Solution for Injection for Cattle and Pigs, which replaces the company's previously animal-specific Baytril Max products.
Bayer says the active ingredient, enrofloxacin, treats bacterial infection by inhibiting the action of bacterial DNA gyrase resulting in bacterial cell death.
In cattle, Baytril Max treats respiratory infections and mastitis caused by enrofloxacin-sensitive Histophilus somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma spp., and enrofloxacin-sensitive E. coli respectively.
In pigs, Baytril Max targets bacterial bronchopneumonia caused by enrofloxacin-sensitive Actinobacillus pleuropneumoniae, Pasteurella multocida and complicated by Haemophilus parasuis as a secondary pathogen in pigs.
Bayer advises that vets treating cattle for respiratory infections should inject subcutaneously. Mastitis cases should be treated intravenously and pigs should be injected intramuscularly in the neck muscles, behind the ear.
The development of the Baytril Max product family provides vets with greater treatment flexibility from one solution.
For further information please visit www.noahcompendium.co.uk
The company says that recent supply issues have been due to 'incredible' demand for Reconcile since it was launched in the UK in 2022, which greatly surpassed expectations.
Dr Lucy Chadwick, Head of Technical Services & Marketing at Forte Healthcare Ltd said: “We realise that the recent supply issues have been very inconvenient so we thank all of our customers for their patience and support during this challenging time.
"We are confident that our supply issues to date have been resolved and that we have enough stock going forward to meet market demand.“
www.reconcilefordogs.com
Canaural contains fusidic acid, framycetin and nystatin for their antibacterial and antifungal effects against the most common organisms associated with otitis externa.
Fusidic acid has skin penetrating properties and is active against staphylococci and streptococci1. Framycetin is active against Gram negative species. Dechra says the combination of the two provides an enhanced antibacterial effect on the most common bacterial cause of canine otitis2.
Nystatin is active against malassezia and prednisolone helps to provide anti-inflammatory and anti-pruritic action.
Dechra Brand Manager Carol Morgan said: “The reintroduction of Canaural to the veterinary treatment market means that once again veterinarians have this reliable and effective treatment available to tackle one of the most common canine complaints.
"Canaural is a tried and tested product and a recent study showed that fusidic acid is highly efficacious against both methicillin sensitive and methicillin resistant strains of Staphylococcus pseudintermedius3. Canaural remains as relevant today as it has ever been."
Canaural comes in 15 ml and 25 ml bottle sizes and is now available in veterinary wholesalers.
Elanco Companion Animal Health has launched of Dexdomitor 0.1 mg/ml, adding to its range of alpha-2 agonists and antagonists.
Produced and manufactured in partnership with Orion Corporation, Elanco says Dexdomitor 0.1 mg/ml contains all the properties of dexmedetomidine in a formulation that allows accurate and convenient dosing for the smallest patients. It can be used as a sedative for non-invasive, mild to moderately painful procedures and examinations which require restraint, sedation and analgesia in dogs and cats. It can also be used for deep sedation and analgesia in dogs in concomitant use with butorphanol for medical and minor surgical procedures and as a pre-medication in dogs and cats before induction and maintenance of general anaesthesia.
Dexdomitor 0.1 mg/ml has been designed to provide accurate dosing in very small dogs (up to 5kg) for sedation and pre-medication, small to mid-size dogs (up to 20kg) for pre-medication, and small cats (up to 3kg) for sedation and pre-medication.
Ed Whittle MRCVS, technical consultant at Elanco Companion Animal Health said: "With nearly a quarter of dogs weighing less than 6kg and nearly three-quarters weighing less than 23.1kg1, Dexdomitor 0.1mg/ml is ideal for small animals that require low concentration doses of dexmedetomidine for convenient and accurate dosing".
Elanco has has also produced a sedation and pre-medication dosing guide to educate veterinary professionals on the recommended doses for its range of alpha-2 agonists and alpha-2 antagonists.
For further information contact your Elanco Companion Animal Health key account manager or email elancoCAH.uk@elanco.com.